Friday, 17 March 2017

The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumour Metastatic Dissemination

Tumour Metastatic Dissemination

Colorectal cancer represents one of the most frequent human neoplasia in Western Countries. Patient prognosis dramatically decreases in advanced tumour stage, when tumour cells acquire the capability to leave the primary tumour site and invade lymph nodes or distant organs.

Chemokines and chemokine receptors have been largely demonstrated to play a crucial role in tumour metastatic progression, influencing the leukocyte composition of the tumour microenvironment through the recruitment of immune cells and driving tumour cells to distant metastatic sites.

In our recent paper, we unexpectedly found that the concomitant expression of the chemokine CX3CL1 (Fractalkine) and its specific receptor CX3CR1 by colorectal cancer cells strongly enforces homotypic tumour cell adhesion, retaining cells locally and avoiding tumour metastatic dissemination

No comments:

Post a Comment